HighPoint Blog

Membership data poses a significant challenge to operational excellence for pharmaceutical and medical device manufacturers. Because membership data is the foundation of contract management, many of the challenges focus on the manual nature of customer information that manufactures receive on an ongoing basis. The challenges include:

Read More

For most companies who perform worldwide transactions, there is a certain challenge to creating ASP transparency. In an ideal world, all the transactions are properly consolidated and budgeting your price is a kid’s game.

Read More

In 2020, all medical device companies will have completed the implementation of the new medical device regulation. Reading European Union (EU) Regulation 2017/745 of the European Parliament and of the Council of 5 April 2017 on Medical Devices[1], it sounds like many new data requirements.

Read More

Co-written by Ed Koller and Jeff Forgang

Read More

Co-authored by Lori Harris-Stevens, RN, MHA and Kathleen Craft

Is your organization an NCQA-accredited health plan, or a managed behavioral health, care management or population health vendor? Is your healthcare organization shopping for a new population health IT vendor? As part of HighPoint’s continued coverage of the new NCQA Population Health Standards, we want to take a closer look at...

Read More

When presenting at the HighPoint Identification of Medicinal Products (IDMP) workshop in Geneva, Switzerland in April 2016, I compared the IDMP journey not just to any marathon, but to the Jungfrau[1] marathon. The Jungfrau Marathon is one of the best known mountain marathons in the world, in full view of the famous EigerMönch, and Jungfrau mountains in the Bernese Oberland area of the Swiss...

Read More

Multiple “market conditions” are forcing manufacturing companies to rethink global launch strategies, as well as local market access strategies such as interaction with payers, prescribers and authorities in order to achieve the expected Return on Investment and achieve market share. In a sense, the “market conditions” have changed and “traditional” product global launch strategies no longer...

Read More

Co-authored by Yann Chappuis, Life Sciences Consultant

Read More

Recent Posts

Tag